Giant axonal neuropathy. Endocrinological and histological studies

Area of Science:

• Neurology
• Cell Biology
• Genetics

Background:

• Giant axonal neuropathy (GAN) is a rare, progressive neurodegenerative disorder affecting both the peripheral and central nervous systems.
• Early diagnosis and understanding of the underlying pathophysiology are crucial for potential therapeutic interventions.

Observation:

• A 4.5-year-old boy presented with symptoms indicative of widespread neurological involvement.
• Standard tests for vitamin B12 malabsorption and endocrine function were normal.
• Clinical presentation remained unchanged despite treatments with cyanocobalamin and prednisone.

Findings:

• Nerve conduction velocity (NCV), EEG, and CT scans confirmed peripheral and central nervous system involvement.
• Electron microscopy revealed characteristic pili canaliculi in hair and neurofilament bundles within nerve axons.
• Microscopic examination of skin and conjunctiva showed abnormal intermediate-sized filaments in various cell types, including mast cells, fibroblasts, melanocytes, endothelial, and Schwann cells.

Implications:

• The findings support the hypothesis that GAN involves a generalized defect in cytoplasmic microfilament formation.
• This suggests a potential underlying disorder of protein metabolism as the cause of GAN.
• Further research into protein metabolism pathways may uncover novel therapeutic targets for GAN.